Congratulations to #Yuhan for its recent approval of Leclaza (Lazertinib) for lung cancer treatment by Korea’s Ministry of Food and Drug Safety. https://lnkd.in/grU_-jC
Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.
Guardant360®. Test. Take Action.
Address:
3 Fusionopolis Link, # 02-11,
Nexus @ One-North,
Singapore 138543.
Telephone:
+65 63056523 / +65 63056520
WhatsApp Hotline:
+65 8940 0360
Email:
clientservicesamea@guardanthealth.com
Media inquiries:
Guardant Health Japan Corp.
Address:
9F Tokyo Portcity Takeshiba Office Tower,
1-7-1 Kaigan, Minato-ku,
Tokyo, 105-7590, Japan
Email:
© 2019 Guardant Health AMEA ALL RIGHTS RESERVED
